Filed 17 Jul 2026
Last verified 14 Oct 2026Offering in progress. A listing date has not been announced, and proposed terms may change.
Company overview
NuvOx Therapeutics is a clinical-stage biopharmaceutical company. It is developing oxygen therapeutic solutions for diseases where hypoxia, or lack of oxygen, plays a critical role.
- Company country
- United States
Offering details
Base offering, before overallotment
- Exchange
- NYSE American
- Ticker
- NUOX
- Shares offered
- 2,860,000
- Shares after offering
- 13,339,579